Published on 2 Sep 2022 on Yahoo Finance
Wall Street bet big against women’s health company after Roe v. Wade ruling
Short sellers ramped up their bets against a women's contraception developer following the U.S. Supreme Court ruling last month to reverse its landmark Roe v. Wade decision, new data showed.
According to a report from S&P Global Market Intelligence published Wednesday, short interest in Evofem Biosciences (EVFM) – a pharmaceutical company that offers women reproductive and contraceptive care products – surged to over 50% in the aftermath of the ruling June 24.